Zhejiang Aojia Nonwoven Technology Co., Ltd. (“Aojia Nonwoven”) Booth number: A1U33, exhibited at the 94th China International Medical Equipment Fair (CMEF) — Autumn Edition — held 21–24 October 2026 at the Capital International Convention and Exhibition Center in Shunyi, Beijing. Across four days the team presented its medical-grade spunlace portfolio to converters, device manufacturers, hospital sourcing groups and distributors, focused on surgical gowns and drapes, wound dressings, face masks, protective apparel and diagnostic consumable substrates. On-site discussions covered specification, sterilisation compatibility, high-speed converting behaviour and documentation for regulated markets.
CMEF is among the largest medical equipment exhibitions in the Asia-Pacific region, and the 94th edition carried particular weight as the first CMEF held at the Capital International Convention and Exhibition Center. The show ran from 21 to 24 October under the theme “Open China, Healthy World.”
Key figures from the organiser:
The 94th CMEF was not a standalone event but a cluster, running alongside ICMD (medical device design and manufacturing), CRS (rehabilitation and personal health), CECN (elderly care and nursing supplies), Life Care (home medical supplies), the International Smart Health Exhibition, and pet health and emergency rescue shows. Thematically the halls spanned medical imaging, IVD, medical consumables, surgical instruments, smart healthcare, rehabilitation, home care, emergency response and pet health.
For a materials supplier, that breadth matters: CMEF is one of the few venues where the raw-material conversation happens alongside device design, converting equipment and hospital procurement.
Aojia’s presentation centered on hydroentangled (spunlace) nonwovens engineered for medical conversion. Rather than a fixed catalogue, the team discussed configurable construction ranges, because medical converters rarely buy a commodity—they buy a fabric that has to run on a specific line, seal a specific way and pass a specific protocol.
Across all categories, specifications are a design space, not a fixed promise: grammage, working width, fibre blend, finish and embossing are customised to the converter’s process and end-use standard.
Hydroentanglement is a mechanical bonding process: high-pressure water jets entangle a fibre web so it holds together without chemical binders. That single characteristic explains most of spunlace’s medical appeal.
A binder-free web removes a variable from biocompatibility and extractables discussions. It leaves the fabric soft and drapeable, which matters more than buyers admit—a stiff gown or scratchy dressing changes how a clinician wears a product. Because the bond is mechanical, the fabric retains much of the parent fibre’s strength, and critically, retains strength when wet, where many bonded nonwovens fail in surgical and wound-care settings.
Spunlace also gives engineers a wide design window: fibre selection, web formation and jet energy can be tuned to shift the balance between barrier and breathability, absorbency and strength, bulk and conformability. That tunability is why one platform serves a barrier gown, a dressing contact layer and a laboratory wipe.
The material is also compatible with the sterilisation routes manufacturers actually use—ethylene oxide, irradiation and steam among them—subject to validation on the specific construction and cycle. Compatibility is confirmed per project rather than assumed, where testing discipline becomes the differentiator.
For buyers managing dual sourcing or qualification timelines, the practical value is a supplier that moves from a target standard to a physical trial roll without a long chain of intermediaries. Learn more about Aojia Nonwoven.
Several themes recurred across the halls, independent of any single booth.
Diagnostics is pulling materials forward. As IVD expands beyond central laboratories into point-of-care testing, each step outward multiplies the single-use consumables per test—swab and sample-handling substrates, wipes, carrier layers—and raises the bar on lot consistency and particle shedding. Materials once specified loosely now go into device documentation.
Single-use sterile consumables remain structurally strong. Infection-control practice, outpatient procedure growth and an ageing population all point the same way. Commercial pressure sits on cost per unit; technical pressure sits on documentation—sterilisation validation, biocompatibility data and traceability are now routine parts of a first enquiry.
Sustainability has become a specification line, not a slogan. Buyers ask about recycled content, fibre provenance and end-of-life options. For medical use the near-term answer is incremental: recycled PET where the application permits, lighter grammages that hold performance, and honest documentation of what cannot change without revalidation.
Supply chain resilience came up in nearly every sourcing conversation. Dual sourcing, regional inventory and shorter qualification cycles are now treated as risk management rather than cost optimisation.
Previously, Aojia also exhibited at MEDICA 2025, where medical-grade spunlace was also in focus.
From gown and drape programmes to dressing constructions, masks, filtration layers and diagnostic consumable substrates, the fastest route is a specification conversation followed by physical samples.
Send your target standard, grammage and width range, converting process and sterilisation route, and we will return a recommended construction and sampling plan.
Request samples, specification sheets and TDS:
Website: https://www.spunlacenon-wovenfabric.com
Tel: +86-139 0573 1202
Email: info@spunlacenon-wovenfabric.com | wade@spunlacenon-wovenfabric.com
Address: No. 398, Huanzhen West Road, Xincheng Town, Xiuzhou District, Jiaxing City, Zhejiang Province, China. You can also contact us online.
